Form D — Aspira Women's Health Inc.
0001493152-25-014101 · filed Sep 18, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $2,950,000
- Reported amount sold
- $2,950,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Aspira Women's Health Inc.
- CIK
- 926617
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 12117 BEE CAVES ROAD
AUSTIN, Texas 78738 - Phone
- 512-519-0400
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
MICHAEL BUHLE · Executive OfficerAUSTIN, Texas Find on LinkedIn ↗
-
BRIAN HUNGERFORD · Executive OfficerAUSTIN, Texas Find on LinkedIn ↗
-
JACK FRASER · DirectorAUSTIN, Texas Find on LinkedIn ↗
-
JEFFREY COHEN · DirectorAUSTIN, Texas Find on LinkedIn ↗
-
Jane PINE WOOD · DirectorAUSTIN, Texas Find on LinkedIn ↗
-
ELLEN BEAUSANG · DirectorAUSTIN, Texas Find on LinkedIn ↗
-
CYNTHIA HUNDORFEAN · DirectorAUSTIN, Texas Find on LinkedIn ↗
-
WINFRED PARNELL · DirectorAUSTIN, Texas Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗